Randomization-based methods for correcting for treatment changes: Examples from the Concorde trial

Statistics in Medicine

Volumn 18, Issue 19, 1999, Pages 2617-2634

  White, Ian R ^a   Babiker, Abdel G ^b   Walker, Sarah ^b   Darbyshire, Janet H ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; METHODOLOGY; OUTCOMES RESEARCH; PROGNOSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL MODEL;

EID: 0033569975     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19991015)18:19<2617::AID-SIM187>3.0.CO;2-E     Document Type: Article

References (26)

1. White, I. R. and Pocock, S. J. 'Statistical reporting of clinical trials with individual changes from allocated treatment', Statistics in Medicine, 15, 249-262 (1996).
2. Concorde Coordinating Committee. 'Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection', Lancet, 343, 871-881 (1994).
3. Graham, N. 'Concorde trial of immediate versus deferred zidovudine (letter)', Lancet, 343, 1355-1356 (1994).
4. Gore, S. M. and Bird, A. G. 'Concorde trial of immediate versus deferred zidovudine (letter)', Lancet, 343, 1357 (1994).
5. White, I. R., Walker, S., Babiker, A. G. and Darbyshire, J. H. 'Impact of treatment changes on the interpretation of the Concorde trial', AIDS, 11, 999-1006 (1997).
6. Robins, J. M. and Tsiatis, A. A. 'Correcting for non-compliance in randomized trials using rank preserving structural failure time models', Communications in Statistics - Theory and Methods, 20(8), 2609-2631 (1991).
7. Pocock, S. J. Clinical Trials: A Practical Approach, Wiley, 1983.
8. Peduzzi, P., Wittes, J. and Detre, K. 'Analysis as-randomized and the problem of non-adherence: an example from the Veterans Affairs randomized trial of coronary artery bypass surgery', Statistics in Medicine, 12, 1185-1195 (1993).
9. Lagakos, S. W., Lim, L. L.-Y. and Robins, J. M. 'Adjusting for early treatment termination in comparative clinical trials', Statistics in Medicine, 9, 1417-1424 (1990).
10. Robins, J. M. 'Analytic methods for estimating HIV-treatment and cofactor effects', in Ostrow, D. G. and Kessler, R. C. (eds), Methodological Issues in AIDS Behavioural Research, Plenum Press, New York, 1993.
11. Oakes, D., Moss, A. J., Fleiss, J. L., Bigger, J. T., Therneau, T., Eberly, S. W., McDermott, M. P., Manatunga, A., Carleen, E., Benhorin, J. and the Multicenter Diltiazem Post-Infarction Trial Research Group. 'Use of compliance measures in an analysis of the effect of diltiazem on mortality and reinfarction after myocardial infarction', Journal of the American Statistical Association, 88, 44-49 (1993).
12. Newcombe, R. G. 'Explanatory and pragmatic estimates of the treatment effect when deviations from allocated treatment occur', Statistics in Medicine, 7, 1179-1186 (1988).
13. Robins, J. M. 'Correcting for non-compliance in randomized trials using structural nested mean models', Communications in Statistics - Theory and Methods, 23, 2379-2412 (1994).
14. Sommer, A. and Zeger, S. L. 'On estimating efficacy from clinical trials', Statistics in Medicine, 10, 45-52 (1991).
15. Cuzick, J., Edwards, R. and Segnan, N. 'Adjusting for non-compliance and contamination in randomized controlled trials', Statistics in Medicine, 16, 1017-1029 (1997).
16. Angrist, J. D., Imbens, G. W. and Rubin, D. B. 'Identification of causal effects using instrumental variables', Journal of the American Statistical Association, 91, 444-455 (1996).
17. Law, M. G. and Kaldor, J. M. 'Survival analysis of randomized clinical trials adjusted for patients who switch treatments', Statistics in Medicine, 15, 2069-2076 (1996).
18. White, I. R. 'Survival analysis of randomized clinical trials adjusted for patients who switch treatments (letter)', Statistics in Medicine, 16, 2619-2620 (1997).
19. Robins, J. M. and Greenland, S. 'Adjusting for differential rates of prophylaxis therapy for PCP in high-dose versus low-dose AZT treatment arms in an AIDS randomized trial", Journal of the American Statistical Association, 89, 737-749 (1994).
20. Mark, S. D. and Robins, J. M. 'A method for the analysis of randomised trials with compliance information: an application to the multiple risk factor intervention trial', Controlled Clinical Trials, 14, 79-97 (1993).
21. Cox, D. R. and Oakes, D. Analysis of Survival Data, Chapman and Hall, London, 1984.
22. Efron, B. and Tibshirani, R.J. An Introduction to the Bootstrap, Chapman and Hall, London, 1993.
23. Clayton, D. G. 'A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence', Biometrika, 65, 141-151 (1978).
24. Oakes, D. 'A model for association in bivariate survival data', Journal of the Royal Statistical Society, Series B, 44, 414-422 (1982).
25. Volberding, P. A., Lagakos, S. W., Grimes, J. M., Stein, D. S., Rooney, J., Meng, T.-C., Fischl, M. A., Collier, A. C., Phair, J. P., Hirsch, M. S., Hardy, W. D., Balfour, H. H. and Reichman, R. C. 'A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 counts for 500 or more per cubic millimeter', New England Journal of Medicine, 333, 401-407 (1995).
26. White, I.R. and Goetghebeur, E. J. T. 'Clinical trials comparing two treatment policies: which aspects of the treatment policies make a difference?', Statistics in Medicine, 17, 319-339 (1998).